Real-life Wrist Movement Patterns Capture Motor Impairment in Individuals with Ataxia-Telangiectasia.

Authors:
Gupta AS; Luddy AC; Khan NC; Reiling S; Thornton JK.

Journal:
Cerebellum

Publication Year: 2022

DOI:
10.1007/s12311-022-01385-5

PMCID:
PMC8926103

PMID:
35294727

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cerebellum

Abbreviation: Cerebellum

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Brain

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Altered binaural hearing in pre-ataxic and ataxic mutation carriers of spinocerebellar ataxia type …
Jacobi H; Andermann M; Faber J and 2 more (2023) - Transparency Score: 4/6
Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA).
Manto M; Hadjivassiliou M; Baizabal-Carvallo JF and 7 more (2023) - Transparency Score: 2/6
Perceptual and Acoustic Analysis of Speech in Spinocerebellar ataxia Type 1.
van Prooije T; Knuijt S; Oostveen J and 3 more (2023) - Transparency Score: 3/6
Quantitative Oculomotor Assessment in Hereditary Ataxia: Discriminatory Power, Correlation with Sev…
Garces P; Antoniades CA; Sobanska A and 12 more (2023) - Transparency Score: 3/6
The Care and Management of Children and Young People with Ataxia Telangiectasia Provided by Nurses …
Khan M; Cassidy E; Parkin T and 14 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics ApprovalWritten informed consent and assent were obtained from all participants prior to participation, and the study was approved by the Partners Healthcare Research Committee Institutional Review Board (No. 2019P002752). Conflict of InterestThe authors declare no competing interests. Conflict of Interest The authors declare no competing interests."

Evidence found in paper:

"Funding ASG is a consultant for Biogen Inc., Triplet Therapeutics, and Remix Therapeutics and is funded by NINDS R01 NS117826, the Massachusetts Life Sciences Center, Biogen Inc., the Ataxia-Telangiectasia Children’s Project, and the University of Pennsylvania Orphan Disease Center. ACL, NCK, SR, and JKT have no disclosures to report."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025